These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 37242892)

  • 1. Hyaluronic Acid-Based Nanocarriers for Anticancer Drug Delivery.
    Fu CP; Cai XY; Chen SL; Yu HW; Fang Y; Feng XC; Zhang LM; Li CY
    Polymers (Basel); 2023 May; 15(10):. PubMed ID: 37242892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticancer therapeutics: targeting macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan receptor.
    Platt VM; Szoka FC
    Mol Pharm; 2008; 5(4):474-86. PubMed ID: 18547053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyaluronic acid-based drug nanocarriers as a novel drug delivery system for cancer chemotherapy: A systematic review.
    Salari N; Mansouri K; Valipour E; Abam F; Jaymand M; Rasoulpoor S; Dokaneheifard S; Mohammadi M
    Daru; 2021 Dec; 29(2):439-447. PubMed ID: 34499323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyaluronic acid and albumin based nanoparticles for drug delivery.
    Lei C; Liu XR; Chen QB; Li Y; Zhou JL; Zhou LY; Zou T
    J Control Release; 2021 Mar; 331():416-433. PubMed ID: 33503486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzyme/GSH/pH-responsive hyaluronic acid grafted porous silica nanocarriers bearing Ag
    Hou J; Zhao Y; Sun L; Zou X
    Carbohydr Polym; 2023 Apr; 305():120547. PubMed ID: 36737216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyaluronic acid for anticancer drug and nucleic acid delivery.
    Dosio F; Arpicco S; Stella B; Fattal E
    Adv Drug Deliv Rev; 2016 Feb; 97():204-36. PubMed ID: 26592477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyaluronic Acid-Coated Nanomedicine for Targeted Cancer Therapy.
    Kim K; Choi H; Choi ES; Park MH; Ryu JH
    Pharmaceutics; 2019 Jun; 11(7):. PubMed ID: 31262049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyaluronic acid-based nano drug delivery systems for breast cancer treatment: Recent advances.
    Jia Y; Chen S; Wang C; Sun T; Yang L
    Front Bioeng Biotechnol; 2022; 10():990145. PubMed ID: 36091467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyaluronic Acid-Based Theranostic Nanomedicines for Targeted Cancer Therapy.
    Lee SY; Kang MS; Jeong WY; Han DW; Kim KS
    Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32290285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of Soft Nanocarriers Combining Hyaluronic Acid with Another Functional Polymer for Cancer Therapy and Other Biomedical Applications.
    Rippe M; Cosenza V; Auzély-Velty R
    Pharmaceutics; 2019 Jul; 11(7):. PubMed ID: 31311150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of chitosan-based nanocarriers in tumor-targeted drug delivery.
    Ghaz-Jahanian MA; Abbaspour-Aghdam F; Anarjan N; Berenjian A; Jafarizadeh-Malmiri H
    Mol Biotechnol; 2015 Mar; 57(3):201-18. PubMed ID: 25385004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD44-Targeted Nanocarrier for Cancer Therapy.
    Kesharwani P; Chadar R; Sheikh A; Rizg WY; Safhi AY
    Front Pharmacol; 2021; 12():800481. PubMed ID: 35431911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyaluronic acid-modified mesoporous silica-coated superparamagnetic Fe
    Fang Z; Li X; Xu Z; Du F; Wang W; Shi R; Gao D
    Int J Nanomedicine; 2019; 14():5785-5797. PubMed ID: 31440047
    [No Abstract]   [Full Text] [Related]  

  • 15. Nanoparticle-based materials in anticancer drug delivery: Current and future prospects.
    Ajith S; Almomani F; Elhissi A; Husseini GA
    Heliyon; 2023 Nov; 9(11):e21227. PubMed ID: 37954330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyaluronic acid and its derivatives in drug delivery and imaging: Recent advances and challenges.
    Tripodo G; Trapani A; Torre ML; Giammona G; Trapani G; Mandracchia D
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt B):400-16. PubMed ID: 26614559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyaluronan-based Multifunctional Nano-carriers for Combination Cancer Therapy.
    Gao M; Deng H; Zhang W
    Curr Top Med Chem; 2021; 21(2):126-139. PubMed ID: 32962617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facile strategy by hyaluronic acid functional carbon dot-doxorubicin nanoparticles for CD44 targeted drug delivery and enhanced breast cancer therapy.
    Li J; Li M; Tian L; Qiu Y; Yu Q; Wang X; Guo R; He Q
    Int J Pharm; 2020 Mar; 578():119122. PubMed ID: 32035259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. pH/reduction dual-responsive hyaluronic acid-podophyllotoxin prodrug micelles for tumor targeted delivery.
    Li M; Zhao Y; Sun J; Chen H; Liu Z; Lin K; Ma P; Zhang W; Zhen Y; Zhang S; Zhang S
    Carbohydr Polym; 2022 Jul; 288():119402. PubMed ID: 35450654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a Hyaluronic Acid-Based Nanocarrier Incorporating Doxorubicin and Cisplatin as a pH-Sensitive and CD44-Targeted Anti-Breast Cancer Drug Delivery System.
    Yu T; Li Y; Gu X; Li Q
    Front Pharmacol; 2020; 11():532457. PubMed ID: 32982750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.